Active Ingredient History

  • Now
Dexmedetomide (biologically active dextroisomer of medetomidine) is an alpha2-adrenergic agonist which was approved by FDA for the sedation purposes. Upon administration the drug activates the alpha2 receptors thus inhibiting the release of norepinephrine and terminating the propagation of pain signals. Also it inhibits sympathetic activity and thus can decrease blood pressure and heart rate.   NCATS

More Chemistry

Drug Pricing (per unit)

United States

$4.6836 - $61.5080
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

(+)-4-((s)-alpha,2,3-trimethylbenzyl)imidazole | deksmedetomidine | dexdor | dexmedethomidine | dexmedetmoidine | dexmedetomedine | dexmedetomidin | dexmedetomidina | dexmedetomidine | dexmédétomidine | dexmedetomidine hcl | dexmedetomidine hydrochloride | dexmedetomidinum | (+)-medetomidine | mexmedetomidine | mpv1440 | mpv-1440 | precedex | (s)-medetomidine


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue